ForSight Vision5, which is developing devices to treat front-of-the-eye conditions such as glaucoma and dry eye disease, said today that it raised another $7.8 million.
ForSight Vision5 is a spinout of ForSight Labs, a Menlo Park, Calif.-based incubator focused on developing ophthalmic treatments. Last year the company reeled in a $15 million Series C round.
Help employers find you! Check out all the jobs and post your resume.
